| 000 | 01582 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516113331.0 | ||
| 264 | 0 | _c20130411 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1879-1484 | ||
| 024 | 7 |
_a10.1016/j.atherosclerosis.2012.09.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchirmer, Stephan H | |
| 245 | 0 | 0 |
_aEffects of omega-3 fatty acids on postprandial triglycerides and monocyte activation. _h[electronic resource] |
| 260 |
_bAtherosclerosis _cNov 2012 |
||
| 300 |
_a166-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aChemokine CCL2 _xblood |
| 650 | 0 | 4 |
_aChemokine CX3CL1 _xblood |
| 650 | 0 | 4 | _aCholesterol |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
| 650 | 0 | 4 | _aDietary Fats |
| 650 | 0 | 4 |
_aFatty Acids, Omega-3 _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aPostprandial Period _xdrug effects |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aWerner, Christian M | |
| 700 | 1 | _aBinder, Stephan B G | |
| 700 | 1 | _aFaas, Maria E | |
| 700 | 1 | _aCustodis, Florian | |
| 700 | 1 | _aBöhm, Michael | |
| 700 | 1 | _aLaufs, Ulrich | |
| 773 | 0 |
_tAtherosclerosis _gvol. 225 _gno. 1 _gp. 166-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.atherosclerosis.2012.09.002 _zAvailable from publisher's website |
| 999 |
_c22140421 _d22140421 |
||